Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-011668

Exec. Director, Finance - PAO acquired 4,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Jones Michael L · Exec. Director, Finance - PAO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-03-18 Exercise or conversion : show line 1 in the form +4,500 $3.51 $15,795 5,348 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-18 Exercise or conversion : show line 2 in the form Emp. Stock Option (Right to Buy) −4,500 0 D
Loading xslF345X03/form4.xml…